These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22128104)

  • 1. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.
    Dinger J; Shapiro S
    J Fam Plann Reprod Health Care; 2012 Jan; 38(1):2-6. PubMed ID: 22128104
    [No Abstract]   [Full Text] [Related]  

  • 2. Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism.
    Leppée M; Culig J
    J Fam Plann Reprod Health Care; 2012 Apr; 38(2):137-8. PubMed ID: 22454018
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it ethical to use drospirenone-containing combined oral contraceptives?
    Pittrof R
    J Fam Plann Reprod Health Care; 2012 Jul; 38(3):205-6; author reply 206-7. PubMed ID: 22787258
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraceptives and venous thromboembolism.
    Graham A; Grieve F; Davie J; Glasier A
    Lancet; 1995 Nov; 346(8987):1430. PubMed ID: 7475846
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of combined oral contraceptive pills.
    Cramer DW
    Lancet; 1996 Feb; 347(9000):546-8. PubMed ID: 8596297
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral contraceptives and venous thromboembolism: an epidemiological review.
    Lidegaard O
    Eur J Contracept Reprod Health Care; 1996; 1(1):13-20. PubMed ID: 9678133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):5-7. PubMed ID: 8920631
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
    Sehovic N; Smith KP
    Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of blood clots higher for oral contraceptives with certain progestins.
    Voelker R
    JAMA; 2011 Nov; 306(20):2206. PubMed ID: 22110099
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral contraceptives and venous thromboembolism: old questions revisited.
    Dinger J
    J Fam Plann Reprod Health Care; 2009 Oct; 35(4):211-3. PubMed ID: 19849911
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of acute myocardial infarction and low-dose combined oral contraceptives.
    Jick H; Jick S; Myers MW; Vasilakis C
    Lancet; 1996 Mar; 347(9001):627-8. PubMed ID: 8596366
    [No Abstract]   [Full Text] [Related]  

  • 14. The risk of deep venous thrombosis with oral contraceptives containing drospirenone.
    Dunn N
    BMJ; 2011 Apr; 342():d2519. PubMed ID: 21511807
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in prescription patterns of oral contraceptives in a northern Italian province: relation with venous thromboembolism.
    Girolami A; Spiezia L; Vianello F; Girolami B; Fabris F
    Clin Appl Thromb Hemost; 2003 Apr; 9(2):125-30. PubMed ID: 12812381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone-based contraceptive therapy and risk of venous thromboembolism in young women.
    Roberts H
    Clin Adv Hematol Oncol; 2010 May; 8(5):307-9. PubMed ID: 20551888
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
    Vinogradova Y; Coupland C; Hippisley-Cox J
    BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of desogestrel, the first new-generation progestagen, practil 21, on 13,290 women and 74,967 cycles].
    Bilotta P; Favilli S
    Minerva Ginecol; 1987 Dec; 39(12):855-69. PubMed ID: 3329705
    [No Abstract]   [Full Text] [Related]  

  • 19. Third generation oral contraceptives.
    Skegg DC
    BMJ; 2000 Jul; 321(7255):190-1. PubMed ID: 10903631
    [No Abstract]   [Full Text] [Related]  

  • 20. [What does the micropill bring?].
    Mall-Haefeli M
    Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.